SVA (Sinovac Biotech) Days Payable : 1,472.28 (As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Sinovac Biotech Days Payable?

Sinovac Biotech's average Accounts Payable for the six months ended in Jun. 2024 was $329.4 Mil. Sinovac Biotech's Cost of Goods Sold for the six months ended in Jun. 2024 was $40.8 Mil. Hence, Sinovac Biotech's Days Payable for the six months ended in Jun. 2024 was 1,472.28.

The historical rank and industry rank for Sinovac Biotech's Days Payable or its related term are showing as below:

SVA' s Days Payable Range Over the Past 10 Years
Min: 15.17 Med: 55.33 Max: 5299.24
Current: 5299.24

During the past 13 years, Sinovac Biotech's highest Days Payable was 5299.24. The lowest was 15.17. And the median was 55.33.

SVA's Days Payable is not ranked
in the Biotechnology industry.
Industry Median: 118.35 vs SVA: 5299.24

Sinovac Biotech's Days Payable increased from Jun. 2023 (406.52) to Jun. 2024 (1,472.28). It may suggest that Sinovac Biotech delayed paying its suppliers.

Sinovac Biotech Days Payable Historical Data

The historical data trend for Sinovac Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinovac Biotech Days Payable Chart

Sinovac Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

63.59

98.68

15.17

20.91

37.32

Sinovac Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															140.94	75.13	406.52	-	1,472.28

Competitive Comparison of Sinovac Biotech's Days Payable

For the Biotechnology subindustry, Sinovac Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinovac Biotech's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Sinovac Biotech's Days Payable falls into.

Save Embed

;

Save Embed

;

Sinovac Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sinovac Biotech's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (19.825	+	17.291)	/	2 )	/	181.516	*	365
=	18.558					/	181.516	*	365
=	37.32

Sinovac Biotech's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (17.291	+	641.579)	/	2 )	/	40.836	*	365 / 2
=	329.435					/	40.836	*	365 / 2
=	1,472.28

Sinovac Biotech Days Payable Related Terms

Thank you for viewing the detailed overview of Sinovac Biotech's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinovac Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinovac Biotech Ltd (NAS:SVA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085

Website

http://www.sinovac.com

Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.

Executives

Lily Wang	director, 10 percent owner, officer: Chief Financial Officer	300 MURCHISON DR., MILLBRAE CA 94030
Ifg Investments Services Inc	10 percent owner	PO BOX 822, CHARLESTOWN FEDERATION OF ST KITTS & NEVIS WEST INDIES P8 00000
Yin Weidong	director, 10 percent owner, officer: President and CEO
Terry G Bowering	director, 10 percent owner, officer: President, CEO	10 CEDAR MEADOW DRIVE REGINA A9 S4X 3J6